$RCKT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ROCKET PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ROCKET PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ROCKET PHARMACEUTICALS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17 2016 | ITEK | INOTEK PHARMACEUTI ... | CARROLL J MARTIN | Director | Buy | P | 9.03 | 10,000 | 90,294 | 10,000 | 0 to 10 K |
| Apr 04 2016 | ITEK | INOTEK PHARMACEUTI ... | CARROLL J MARTIN | Director | Option Exercise | A | 7.63 | 24,000 | 183,120 | 24,000 | |
| Mar 24 2016 | ITEK | INOTEK PHARMACEUTI ... | RITTER DALE | Vice President, Fin ... | Option Exercise | A | 7.56 | 40,000 | 302,400 | 40,000 | |
| Mar 24 2016 | ITEK | INOTEK PHARMACEUTI ... | Baumgartner Rudolph | See Remarks | Option Exercise | A | 7.56 | 165,000 | 1,247,400 | 165,000 | |
| Mar 24 2016 | ITEK | INOTEK PHARMACEUTI ... | McVicar William K. | See Remarks | Option Exercise | A | 7.56 | 135,000 | 1,020,600 | 135,000 | |
| Mar 24 2016 | ITEK | INOTEK PHARMACEUTI ... | SOUTHWELL DAVID P | See Remarks | Option Exercise | A | 7.56 | 215,000 | 1,625,400 | 215,000 | |
| Jan 12 2016 | ITEK | INOTEK PHARMACEUTI ... | BOESS CARSTEN | Director | Option Exercise | A | 8.89 | 24,000 | 213,360 | 24,000 | |
| Nov 18 2015 | ITEK | INOTEK PHARMACEUTI ... | Rho Ventures IV Holdings LLC | 10% Owner | Sell | J | 0.00 | 127,711 | 0 | 0 | 127.7 K to 0 (-100.00 %) |
| Nov 18 2015 | ITEK | INOTEK PHARMACEUTI ... | Rho Ventures IV Holdings LLC | 10% Owner | Sell | J | 0.00 | 115,083 | 0 | 636,496 | 751.6 K to 636.5 K (-15.31 %) |
| Oct 13 2015 | ITEK | INOTEK PHARMACEUTI ... | Phillips Gary M. | Director | Option Exercise | A | 9.50 | 24,000 | 228,000 | 24,000 | |
| Jul 20 2015 | ITEK | INOTEK PHARMACEUTI ... | Spivey Richard N. | Director | Option Exercise | A | 5.32 | 24,000 | 127,680 | 24,000 | |
| Jul 16 2015 | ITEK | INOTEK PHARMACEUTI ... | Devon Park Associates, L.P. | 10% Owner | Option Exercise | M | 4.34 | 9,857 | 42,799 | 0 | |
| Jul 16 2015 | ITEK | INOTEK PHARMACEUTI ... | Devon Park Associates, L.P. | 10% Owner | Buy | M | 4.34 | 9,857 | 42,799 | 3,253,566 | 3.2 M to 3.3 M (+0.30 %) |
| Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | CARE CAPITAL II LLC | 10% Owner | Option Exercise | A | 5.03 | 12,000 | 60,360 | 21,857 | |
| Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | SOUTHWELL DAVID P | See Remarks | Option Exercise | A | 5.03 | 150,000 | 754,500 | 548,497 | |
| Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | Peimer Isai | Director | Option Exercise | A | 5.03 | 12,000 | 60,360 | 21,857 | |
| Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | VOGELBAUM MARTIN | Director | Option Exercise | A | 5.03 | 12,000 | 60,360 | 21,857 | |
| Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | RITTER DALE | Vice President, Fin ... | Option Exercise | A | 5.03 | 25,000 | 125,750 | 68,982 | |
| Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Option Exercise | A | 5.03 | 12,000 | 60,360 | 21,857 | |
| Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | McVicar William K. | See Remarks | Option Exercise | A | 5.03 | 75,000 | 377,250 | 276,094 | |
| Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | HOWES PAUL G | Director | Option Exercise | A | 5.03 | 12,000 | 60,360 | 28,017 | |
| Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | Baumgartner Rudolph | See Remarks | Option Exercise | A | 5.03 | 75,000 | 377,250 | 276,615 | |
| Jun 26 2015 | ITEK | INOTEK PHARMACEUTI ... | Harel Ittai | Director | Option Exercise | A | 5.03 | 12,000 | 60,360 | 21,857 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Pitango Venture Capital Princi ... | 10% Owner | Option Exercise | C | 0.00 | 225,747 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Pitango Venture Capital Princi ... | 10% Owner | Option Exercise | C | 0.00 | 2,676,348 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Pitango Venture Capital Princi ... | 10% Owner | Buy | P | 6.00 | 212,375 | 1,274,250 | 1,292,584 | 1.1 M to 1.3 M (+19.66 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Pitango Venture Capital Princi ... | 10% Owner | Buy | C | 0.00 | 38,143 | 0 | 1,080,209 | 1 M to 1.1 M (+3.66 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Pitango Venture Capital Princi ... | 10% Owner | Buy | C | 0.00 | 847,424 | 0 | 1,042,066 | 194.6 K to 1 M (+435.38 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Option Exercise | C | 0.00 | 4,459,658 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Buy | P | 6.00 | 603,832 | 3,622,992 | 2,277,139 | 1.7 M to 2.3 M (+36.09 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Buy | C | 0.00 | 63,560 | 0 | 1,673,307 | 1.6 M to 1.7 M (+3.95 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | KARABELAS ARGERIS N | Director | Buy | C | 0.00 | 1,394,645 | 0 | 1,609,747 | 215.1 K to 1.6 M (+648.36 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | CARE CAPITAL II LLC | 10% Owner | Option Exercise | C | 0.00 | 4,459,658 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | CARE CAPITAL II LLC | 10% Owner | Buy | P | 6.00 | 603,832 | 3,622,992 | 2,277,139 | 1.7 M to 2.3 M (+36.09 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | CARE CAPITAL II LLC | 10% Owner | Buy | C | 0.00 | 63,560 | 0 | 1,673,307 | 1.6 M to 1.7 M (+3.95 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | CARE CAPITAL II LLC | 10% Owner | Buy | C | 0.00 | 1,394,645 | 0 | 1,609,747 | 215.1 K to 1.6 M (+648.36 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | RHO VENTURES IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 432,591 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | RHO VENTURES IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 5,128,577 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | RHO VENTURES IV QP LP | 10% Owner | Buy | P | 6.00 | 958,226 | 5,749,356 | 2,870,584 | 1.9 M to 2.9 M (+50.11 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | RHO VENTURES IV QP LP | 10% Owner | Buy | C | 0.00 | 73,092 | 0 | 1,912,358 | 1.8 M to 1.9 M (+3.97 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | RHO VENTURES IV QP LP | 10% Owner | Buy | C | 0.00 | 1,606,230 | 0 | 1,839,266 | 233 K to 1.8 M (+689.26 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Kantesaria Devang | 10% Owner | Option Exercise | C | 0.00 | 626,943 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Kantesaria Devang | 10% Owner | Option Exercise | C | 0.00 | 7,432,720 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Kantesaria Devang | 10% Owner | Buy | P | 6.00 | 814,166 | 4,884,996 | 3,243,709 | 2.4 M to 3.2 M (+33.51 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Kantesaria Devang | 10% Owner | Buy | C | 0.00 | 105,933 | 0 | 2,429,543 | 2.3 M to 2.4 M (+4.56 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | Kantesaria Devang | 10% Owner | Buy | C | 0.00 | 2,323,610 | 0 | 2,323,610 | 0 to 2.3 M |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 626,943 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 7,432,720 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Buy | P | 6.00 | 814,166 | 4,884,996 | 3,243,709 | 2.4 M to 3.2 M (+33.51 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Buy | C | 0.00 | 105,933 | 0 | 2,429,543 | 2.3 M to 2.4 M (+4.56 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Buy | C | 0.00 | 2,323,610 | 0 | 2,323,610 | 0 to 2.3 M |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 338,551 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 4,013,692 | 0 | 0 | |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 6.00 | 416,667 | 2,500,002 | 1,917,906 | 1.5 M to 1.9 M (+27.75 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 57,204 | 0 | 1,501,239 | 1.4 M to 1.5 M (+3.96 %) |
| Feb 25 2015 | ITEK | INOTEK PHARMACEUTI ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 1,255,123 | 0 | 1,444,035 | 188.9 K to 1.4 M (+664.40 %) |